Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.
Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center has participated in 1 clinical trials.
Therapeutic areas: Relapsed/Refractory Acute Leukemia.
Sponsors: Syndax Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Massachusetts · View every site in Boston
Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center has 1 clinical trials on record. Their work covers Relapsed/Refractory Acute Leukemia.
Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.